identified KMT2C as a target of deleterious mutations as well as copy losses at chromosome 7 and showed its tumor-suppressive role in acute myeloid leukemia, though KMT2C knockdown was incapable to drive oncogenesis alone (54). This evidence concerns the gene KMT2C and neoplasm.